cannepil

the proof is in the packaging

CannEpil™ is CBD-based medication that is used as a treatment for people with refractory epilepsy, and, as announced in November 2017, it was MGC Pharmaceuticals’ first product to market. Hedgehog was tasked with the job of not only naming the product, but designing the product from scratch — this included typeface, colour palette, label layout, copy positioning and box design.